E-LIB Suche - Ergebnisse für: Feliz, Luis

1

Effect of FGFR2 Alterations on Overall and Progression-Free..:

Abou-Alfa, Ghassan K. ; Bibeau, Kristen ; Schultz, Nikolaus...
Targeted Oncology. 17 (2022) 5 - p. 517-527 , 2022

Link: https://doi.org/10.1007/..

2

Experiencia acumulada con casos de bezoar por el departamen..:

Alcántara, Elvyn ; Roa, Firelys ; Espinosa, Juan..
Ciencia y Salud. 5 (2021) 2 - p. 149-157 , 2021

Link: https://doi.org/10.22206..

3

Tumor ovárico, células de la granulomatosa juvenil. A propó..:

Alcántara, Elvyn ; Roa, Firelys ; Díaz, Zaimy..
Ciencia y Salud. 5 (2021) 2 - p. 169-176 , 2021

Link: https://doi.org/10.22206..

4

FIGHT-302: first-line pemigatinib vs gemcitabine plus cispl..:

Bekaii-Saab, Tanios S ; Valle, Juan W ; Van Cutsem, Eric...
Future Oncology. 16 (2020) 30 - p. 2385-2399 , 2020

Link: https://doi.org/10.2217/..

5

Comparative study on the use of three different near infrar..:

Nogales-Bueno, Julio ; Feliz, Luis ; Baca-Bocanegra, Berta...
Talanta. 206 (2020) - p. 120189 , 2020

Link: https://doi.org/10.1016/..

6

Pemigatinib for previously treated, locally advanced or met..:

Abou-Alfa, Ghassan K ; Sahai, Vaibhav ; Hollebecque, Antoine...
The Lancet Oncology. 21 (2020) 5 - p. 671-684 , 2020

Link: https://doi.org/10.1016/..

7

Outcome of patients treated with palliative weekly Paclitax..:

Sosa, Aaron E. ; Grau, Juan J. ; Feliz, Luis...
European Archives of Oto-Rhino-Laryngology. 271 (2013) 2 - p. 373-378 , 2013

Link: https://doi.org/10.1007/..

8

Anti-vascular endothelial growth factor therapy in the era ..:

Féliz, Luis R. ; Tsimberidou, Apostolia M.
Cancer Chemotherapy and Pharmacology. 72 (2013) 1 - p. 1-12 , 2013

Link: https://doi.org/10.1007/..

9

Truncated FGFR2 is a clinically actionable oncogene in mult..:

Zingg, Daniel ; Bhin, Jinhyuk ; Yemelyanenko, Julia...
https://boris.unibe.ch/171911/. , 2022

Link: https://boris.unibe.ch/1..

10

Publisher Correction: Truncated FGFR2 is a clinically actio..:

Zingg, Daniel ; Bhin, Jinhyuk ; Yemelyanenko, Julia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519452/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Progression-Free Survival in Patients With Cholangiocarcino..:

Bibeau, Kristen ; Féliz, Luis ; Lihou, Christine F..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200396/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Publisher Correction: Truncated FGFR2 is a clinically actio..:

Zingg, Daniel ; Bhin, Jinhyuk ; Yemelyanenko, Julia...
https://boris.unibe.ch/172656/. , 2022

Link: https://boris.unibe.ch/1..

13

Effect of FGFR2 Alterations on Overall and Progression-Free..:

Abou-Alfa, Ghassan K ; Bibeau, Kristen ; Schultz, Nikolaus...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512879/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Comparative study on the use of three different near infrar..:

Nogales-Bueno, Julio ; Feliz, Luis ; Baca-Bocanegra, Berta...
Julio Nogales-Bueno, Luis Feliz, Berta Baca-Bocanegra, José Miguel Hernández-Hierro, Francisco José Heredia, João Manuel Barroso, Ana Elisa Rato. Comparative study on the use of three different near infrared spectroscopy recording methodologies for varietal discrimination of walnuts. Talanta, Volume 206,2020.https://doi.org/10.1016/j.talanta.2019.120189. , 2020

Link: http://hdl.handle.net/10..

15

FIGHT-302: first-line pemigatinib vs gemcitabine plus cispl..:

Bekaii-Saab, Tanios S ; Valle, Juan W ; Cutsem, Eric Van...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892961/. , 2020

Link: http://www.ncbi.nlm.nih...